Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by bilosellhion Jul 19, 2004 8:52pm
316 Views
Post# 7724212

RE: Another new paper on Reovirus oncolysis

RE: Another new paper on Reovirus oncolysisdoubledouchebag my post was addressed to PWF - who made you the thought police of stockhouse? who gives a crap what you and your multiple aliases think? you & your friends transparently inundate these boards with mindless hype designed to extoll only BT/onc/reolysin. interesting how your & your alias friends' posting histories suggest you follow every trade of onc, and purport to also be so-called authorities on the reovirus, RAS activation, low ticking, short positions, etc., etc. interesting combination of knowledge there...you & your "friends" couldn't be a broker/trader pumping out the hype for your own benefit, could you now? you are nothing but pumpers & hypers and bad ones at that. maybe time to resurrect that discredited timenhalf imposter? LOL
Bullboard Posts